Lymphokine activated killing of fresh human leukaemias

This publication has 22 references indexed in Scilit:

• Influence of 12-o-tetradecanoylphorbol-13-acetate (TPA) on the susceptibility of K562 to natural cytotoxicity: Evidence for clonal variation in differentiation-induced changes of lytic sensitivity
  International Journal of Cancer, 1984
• Characteristics of human NK clones: target specificity and phenotype.
  The Journal of Immunology, 1984
• Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2.
  The Journal of Experimental Medicine, 1984
• A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cells
  Leukemia Research, 1984
• Induction of proliferation and NK activity in human lymphocytes by mature myelomonocytic cells: evidence for an HLA-DR-independent MLR stimulatory ability of terminally differentiated nonlymphoid leukemic cell lines and of normal peripheral blood granulocytes.
  The Journal of Immunology, 1983
• Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells
  The Journal of Experimental Medicine, 1983
• Susceptibility of human leukaemias to cell-mediated cytotoxicity by interferon-treated allogeneic lymphocytes
  Cancer Immunology, Immunotherapy, 1982
• Spontaneous release of a factor with properties of T cell growth factor from a continuous line of primate tumor T cells.
  The Journal of Immunology, 1981
• Modulation of target cell susceptibility to human natural killer cells by interferon
  International Journal of Cancer, 1980
• Cell-mediated cytotoxicity in relation to active immunotherapy in acute myeloid leukaemia
  Cancer Immunology, Immunotherapy, 1979